Human hematopoietic stem/progenitor‐enriched CD34+ cells are mobilized into peripheral blood during stress related to ischemic stroke or acute myocardial infarction
- 10 November 2005
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 75 (6) , 461-467
Abstract
The hematopoietic and non-hematopoietic stem/progenitor cells harvested directly from the bone marrow (BM) or G-CSF mobilized peripheral blood were demonstrated to play an important role in regeneration of damaged organs ( 1, 2 ). Here, we asked if the stroke- or acute heart infarct-related stress triggers mobilization of stem/progenitor-enriched CD34+cells from the BM into the peripheral blood, which subsequently could contribute to regeneration of damaged tissues. To address this question the peripheral blood samples were harvested from patients with ischemic stroke during the first 24 h of manifestation of symptoms and on the second and sixth day afterwards or during the first 24 h of acute cardiac pain as well as on the second and sixth day of infarct. We measured in these patients (i) percentage of circulating hematopoietic stem/progenitor-enriched CD34+ cells in peripheral blood by employing fluorescence activated cell sorter (FACS) and (ii) number of hematopoietic progenitor cells for the granulocyte-monocytic colony-forming unit (CFU-GM) and erythoid burst-forming unit (BFU-E) lineages circulating in peripheral blood. We concluded that stress related to ischemic stroke or acute myocardial infarction triggers the mobilization of hematopoietic stem/progenitor-enriched CD34+ cells from the BM into peripheral blood. These circulating stem/progenitor-enriched CD34+ cells may contribute to the regeneration of ischemic tissues, however, this possibility requires further studies.Keywords
This publication has 38 references indexed in Scilit:
- Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarctionBlood, 2005
- Comparison of Retroviral Transduction Efficiency in CD34 + Cells Derived from Bone Marrow versus G‐CSF–Mobilized or G‐CSF Plus Stem Cell Factor–Mobilized Peripheral Blood in Nonhuman PrimatesStem Cells, 2004
- The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cellsEuropean Journal of Haematology, 2004
- Bone marrow–derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiationNature Medicine, 2004
- Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarctsNature, 2004
- Characterization of a Lineage‐Negative Stem‐Progenitor Cell Population Optimized for Ex Vivo Expansion and Enriched for LTC‐ICStem Cells, 2004
- Isolation of Bone Marrow Stromal Cell–Derived Smooth Muscle Cells by a Human SM22α PromoterCirculation, 2003
- A Subpopulation of Murine Bone Marrow Cells Fully Differentiates along the Myogenic Pathway and Participates in Muscle Repair in the mdx Dystrophic MouseExperimental Cell Research, 2002
- The Role of Blood Stem Cells in Hematopoietic Cell RenewalStem Cells, 1998
- The Biology of Hematopoietic Stem CellsAnnual Review of Cell and Developmental Biology, 1995